Chen Yu

No. 127 Changle West Road
Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Ivarmacitinib is associated with rapid clinical improvement and immune remodeling in palmoplantar pustulosis: A multicenter, single-arm clinical trial.

Ivarmacitinib is associated with rapid clinical improvement and immune remodeling in palmoplantar pustulosis: A multicenter, single-arm clinical trial.

Journal: Journal of the American Academy of Dermatology

Published: May 22, 2026

Prevalence, characterization, and clinical predictors of advanced systemic therapy-refractory palmoplantar pustulosis: A prospective real-world cohort study.

Prevalence, characterization, and clinical predictors of advanced systemic therapy-refractory palmoplantar pustulosis: A prospective real-world cohort study.

Journal: Journal of the American Academy of Dermatology

Published: March 04, 2026

Biologic Efficacy by BMI in Moderate-To-Severe Psoriasis: A Real-World Cohort Study.

Biologic Efficacy by BMI in Moderate-To-Severe Psoriasis: A Real-World Cohort Study.

Journal: Experimental dermatology

Published: January 06, 2026

Effects of access to primary healthcare services on health vulnerability among older adults in China: focusing on demographic differences.

Effects of access to primary healthcare services on health vulnerability among older adults in China: focusing on demographic differences.

Journal: Frontiers in public health

Published: July 03, 2025

Sequential Use of Apremilast, Total Glucosides of Paeony, and Periodontal Therapy in Refractory Plurimucosal Lichen Planus: A Case Report.

Sequential Use of Apremilast, Total Glucosides of Paeony, and Periodontal Therapy in Refractory Plurimucosal Lichen Planus: A Case Report.

Journal: Case reports in dentistry

Published: March 03, 2025

Extension of Secukinumab and Ixekizumab Dose for Moderate-To-Severe Psoriasis in Low Disease Activity Intervals.

Extension of Secukinumab and Ixekizumab Dose for Moderate-To-Severe Psoriasis in Low Disease Activity Intervals.

Journal: Experimental dermatology

Published: December 11, 2024

Current status of generalized pustular psoriasis: Findings from a multicenter hospital-based survey of 127 Chinese patients.

Current status of generalized pustular psoriasis: Findings from a multicenter hospital-based survey of 127 Chinese patients.

Journal: Chinese medical journal

Published: October 16, 2024

When "Aging" meets "Intelligence": smart health cognition and intentions of older adults in rural Western China.

When "Aging" meets "Intelligence": smart health cognition and intentions of older adults in rural Western China.

Journal: Frontiers in psychiatry

Published: September 09, 2024

BMI matters: understanding the link between weight and severe psoriasis.

BMI matters: understanding the link between weight and severe psoriasis.

Journal: Scientific reports

Published: March 27, 2024

A large-scale retrospective study in China explores risk factors for disease severity in plaque psoriasis.

A large-scale retrospective study in China explores risk factors for disease severity in plaque psoriasis.

Journal: Scientific reports

Published: December 11, 2023

Clinical characteristics and outcomes of psoriasis patients with COVID-19: A retrospective, multicenter cohort study in China.

Clinical characteristics and outcomes of psoriasis patients with COVID-19: A retrospective, multicenter cohort study in China.

Journal: Chinese medical journal

Published: September 26, 2023

Development and validation of a prognostic model for predicting flares in generalized pustular psoriasis.

Development and validation of a prognostic model for predicting flares in generalized pustular psoriasis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 05, 2023

Showing 1-12 of 26

Last Updated: 09/26/2026